Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 hours agovaccines as frequently in the last few years. According to the Centers for Disease Control and...
AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time
Daily Telegraph· 4 days agoIn a letter of response sent in May 2023, AstraZeneca told lawyers for Mr Scott that “we do not...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 1 day agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Statement on the antigen composition of COVID-19 vaccines
World Health Organization· 6 days agoApril 2024 statement on the antigen composition of COVID-19 vaccines
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 9 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 13 hours agoCovid vaccine maker came out of the March quarter with a $3.07 loss per share, reversing from a...
EU drug watchdog urges COVID-19 vaccine update
Medical Xpress· 2 days agoThe most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 1 hour agoThe Spikevax story is over, but... Barring a renewed Covid surge -- fingers crossed! -- there isn't much future in Spikevax. Yet as ever, Moderna...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 19 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 12 hours agoModerna stock soared on Wednesday after its first-quarter earnings report sailed past Wall Street’s...
